MoneyWorks4Me

Syschem (India) reports Profit after tax of Rs 13.40 Mln, in the September 2022 quarter

02 Nov 2022 Evaluate
An increase of about 77.57% to Rs. 224.91 millions in the topline was observed for the quarter ended September 2022. The topline stood at Rs. 126.66 millions during the similar quarter previous year.The Total Profit for the quarter ended September 2022 of Rs. 13.40 millions grew from Rs.-17.13 millions Operating profit Margin for the quarter ended September 2022 improved to 20.74% as compared to -10.57% of corresponding quarter ended September 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 224.91 126.66 77.57 388.49 322.19 20.58 656.33 744.15 -11.80
Other Income 1.34 0.20 570.00 1.85 0.22 740.91 1.26 2.56 -50.78
PBIDT 20.74 -10.57 -296.22 34.73 -19.18 -281.07 6.93 -49.04 -114.13
Interest 0.21 0.22 -4.55 0.28 0.30 -6.67 2.84 0.55 416.36
PBDT 20.53 -10.79 -290.27 34.45 -19.48 -276.85 4.09 -49.59 -108.25
Depreciation 7.13 6.34 12.46 13.96 12.54 11.32 25.81 23.55 9.60
PBT 13.40 -17.13 -178.23 20.49 -32.02 -163.99 -21.72 -73.14 -70.30
TAX 0.00 0.00 0.00 0.00 0.00 0.00 -4.66 -17.49 -73.36
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -4.66 -17.49 -73.36
PAT 13.40 -17.13 -178.23 20.49 -32.02 -163.99 -17.06 -55.65 -69.34
Equity 305.40 232.90 31.13 305.40 232.90 31.13 232.90 215.40 8.12
PBIDTM(%) 9.22 -8.35 -210.50 8.94 -5.95 -250.17 1.06 -6.59 -116.02
Peers
Company Name CMP
Sun Pharma. Inds. 1754.95
Dr. Reddys Labs. 1172.00
Cipla 1294.20
Lupin 1951.00
Zydus Lifesciences 1111.65
View more..